Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PharmaVend24 AB
AB
Active
Org 5594030826
Spjutvägen 9
Retail sale of pharmaceutical products · NACE 4773
Est. 2022
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 0
+100% vs 2023
EBITDA — year on year
SEK millions
0M
0M
1M
1M
1M
-1M
2023
0M
+100%
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
—
—
Net profit
SEK 0
+100%
Total assets
SEK 23,8M
+0%
Equity
SEK 23,8M
+0%
Employees
0
—
Company information
Legal name
PharmaVend24 AB
Org number
5594030826
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
26 oktober 2022
Share capital
SEK 25 000 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva handel och försäljning av läkemedel, apoteksnära handelsvaror samt därmed förenlig verksamhet.
Contact
Address
Spjutvägen 9
Email
ahis7793@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Burlöv
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
-1M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
—
—
EBITDA
−1 200
—
Depreciation & amort.
−0
−0
EBIT
−1 200
0
Net financials
—
—
Profit before tax
−1 200
0
Tax
−0
−0
Net profit
−1 200
0
Balance sheet
SEK thousands
Item
2023
2024
Total assets
23 800
23 800
Equity
23 800
23 800
Long-term debt
0
0
Short-term debt
0
0
Total debt
—
—
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2023
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2023
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2023
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
NC
Nebil Charchafche
Chairman
2022
—
—
AI
Ahmad Ismail Taleb
Board of Directors
2022
—
—
SS
Sarah Sahar Adnan Salman
Deputy Board Member
2022
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of PharmaVend24 AB also hold positions in
0
other companies.
Person
Role here
Other companies
Nebil Charchafche
Chairman
0 companies
Ahmad Ismail Taleb
Board of Directors
0 companies
Sarah Sahar Adnan Salman
Deputy Board Member
0 companies